EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis

Núria Puig iD, Arnau Solé, Ana Aguilera-Simon iD, Raquel Griñán iD, Noemi Rotllan iD, Pol Camps-Renom iD, Sonia Benitez iD

International Journal of Molecular Sciences · 20.09.2023 · 24 (18) · 14325

DOI: 10.3390/ijms241814325 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.09.2023. Verfasst von Núria Puig und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Biochemistry, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), 08041 Barcelona, Spain. Hauptthemen laut MEDLINE: Ischemic Stroke, Carotid Artery Diseases, Atherosclerosis, Stroke. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Insituto de Salud Carlos III, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherothrombotic stroke represents approximately 20% of all ischemic strokes. It is caused by large-artery atherosclerosis, mostly in the internal carotid artery, and it is associated with a high risk of early recurrence. After an ischemic stroke, tissue plasminogen activator is used in clinical practice, although it is not possible in all patients. In severe clinical situations, such as high carotid stenosis (≥70%), revascularization by carotid endarterectomy or by stent placement is carried out to avoid recurrences. In stroke prevention, the pharmacological recommendations are based on antithrombotic, lipid-lowering, and antihypertensive therapy. Inflammation is a promising target in stroke prevention, particularly in ischemic strokes associated with atherosclerosis. However, the use of anti-inflammatory strategies has been scarcely studied. No clinical trials are clearly successful and most preclinical studies are focused on protection after a stroke. The present review describes novel therapies addressed to counteract inflammation in the prevention of the first-ever or recurrent stroke. The putative clinical use of broad-spectrum and specific anti-inflammatory drugs, such as monoclonal antibodies and microRNAs (miRNAs) as regulators of atherosclerosis, will be outlined. Further studies are necessary to ascertain which patients may benefit from anti-inflammatory agents and how.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeCarotid Artery DiseasesAtherosclerosisStrokeHumansTissue Plasminogen ActivatorInflammation

Stichwörter der Autor:innen

atherosclerosisinflammationischemic stroketherapies

Substanzen

Tissue Plasminogen Activator

Autor:innen und Institutionen

  • Cardiovascular Biochemistry, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), 08041 Barcelona, Spain.
  • Department of Biochemistry and Molecular Biology, Faculty of Medicine, Building M, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallés, 08193 Barcelona, Spain.
  • Stroke Unit, Department of Neurology, Hospital de La Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), 08041 Barcelona, Spain.
  • Pathofisiology of Lipid-Related Deseases, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), 08041 Barcelona, Spain.
  • CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Núria Puig, Ana Aguilera-Simon, Raquel Griñán, Noemi Rotllan, Pol Camps-Renom, Sonia Benitez

Förderung

  • Insituto de Salud Carlos III
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia, Innovación y Universidades
  • Agencia Estatal de Investigación
  • CIBER of Diabetes and Metabolic Diseases, Instituto de Salud Carlos III
  • Subprograma Ramó
  • RICORS-ICTUS
  • Quality Research Group

Zitieren

APA

Puig, N., Solé, A., Aguilera-Simon, A., Griñán, R., Rotllan, N., Camps-Renom, P., & Benitez, S. (2023). Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis. International Journal of Molecular Sciences, 24(18), 14325. https://doi.org/10.3390/ijms241814325

Vancouver

Puig N, Solé A, Aguilera-Simon A, Griñán R, Rotllan N, Camps-Renom P, et al. Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis. International Journal of Molecular Sciences. 2023;24(18):14325. doi:10.3390/ijms241814325

BibTeX
@article{Puig2023,
  author = {Puig, Núria and Solé, Arnau and Aguilera-Simon, Ana and Griñán, Raquel and Rotllan, Noemi and Camps-Renom, Pol and Benitez, Sonia},
  title = {Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {18},
  pages = {14325},
  doi = {10.3390/ijms241814325}
}
Kostenlos starten →